All Type of News
Patients survival less in advanced diabetic nephropathy than cancer.
A shocking report revealed that the 5 year survival rate of advanced diabetic nephropathy was only 39.9%, which was far less than 45.9% of cancer patients (based on 2005 MOHW estimate).
The Korea Society of Nephro...
New drugs developed in Korea aiming at U. S. markets.
Local pharmaceutical companies are trying to enter the U. S. markets with new drugs developed in Korea through appropriate clinical studies for the FDA approval.
Starting with Factive, developed by LG Life Science,...
Generic drugs' price-cut plan faces backlash
The government plans to improve financial soundness of the national health insurance by slashing the prices of generic drugs by 20 percent.
The move, however, has immediately triggered a strong backlash from the do...
Pharmacy urged to preserve drug invoices
The Health Insurance Review Agency (HIRA) has called for all proprietors of pharmacy nationwide to keep their evidencing documents involved in the purchase of all drugs for five years from the date of transaction with...
U. S. NIH to finance Samjin viral new compound.
A new anti-viral agent developed by Samjin for the treatment of HIV, an AIDS virus, has been found of its excellent efficacy, and now Samjin may receive a financial support from the U. S. NIH for the development of an...
Boryung's Yonggaksan sales jump 50% in 2006
Borung Pharm said on November 22 its Yonggaksan sales in 2006 jumped more than 50 percent from the previous year, buoyed by robust domestic sales.
Yonggaksan is the most popular brand in the domestic antitussive & ...
Government expedites establishment of new food safety agency
The government said it is accelerating its efforts to establish a food safety agency through the separation of the roles of the Korea Food and Drug Administration (KFDA).
A food sanitation agency will be establish...
Green Cross and OctoPlus signed joint development of new drug for mid-ear infection.
Green Cross signed an agreement with OctoPlus NV, a Netherlands company, on Nov. 22 for an exclusive distribution in Korea and joint development of OP-145, a drug for the treatment of chronic middle ear infection (oti...
KFDA suggests quality control standards for clinical sample drugs.
The KFDA will hold a public hearing meeting at the auditorium of Korea Women Development Board on Nov. 27 on the subject of "The quality control standards for the clinical test sample of the investigational new drug (...
KFDA clarifies drug labeling and description issue
In response to a recent civil petition on the labeling and description provisions of drugs, the Korea Food and Drug Administration said that in case of consigning some packaging process to other toll-manufacturing fir...
